CN111318077A - A multiplexed convection chromatography system and method for purifying protein - Google Patents
A multiplexed convection chromatography system and method for purifying protein Download PDFInfo
- Publication number
- CN111318077A CN111318077A CN201811529395.9A CN201811529395A CN111318077A CN 111318077 A CN111318077 A CN 111318077A CN 201811529395 A CN201811529395 A CN 201811529395A CN 111318077 A CN111318077 A CN 111318077A
- Authority
- CN
- China
- Prior art keywords
- peristaltic pump
- storage tank
- chromatography
- liquid storage
- tangential flow
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Images
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D36/00—Filter circuits or combinations of filters with other separating devices
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
- B01D15/08—Selective adsorption, e.g. chromatography
- B01D15/10—Selective adsorption, e.g. chromatography characterised by constructional or operational features
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/16—Extraction; Separation; Purification by chromatography
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/34—Extraction; Separation; Purification by filtration, ultrafiltration or reverse osmosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/36—Extraction; Separation; Purification by a combination of two or more processes of different types
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Analytical Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Water Supply & Treatment (AREA)
- Peptides Or Proteins (AREA)
Abstract
Description
技术领域technical field
本发明涉及一种复用对流色谱系统及其用于纯化蛋白的方法,属于蛋白纯化技术领域。The invention relates to a multiplexed convection chromatography system and a method for purifying protein thereof, belonging to the technical field of protein purification.
背景技术Background technique
切向流过滤(tangential flow filtration,简称TFF)是一种新型的浓缩过滤技术,是指液体流动方向与过滤方向相垂直的过滤形式。相比于传统的死端过滤(dead end),切向流过滤系统中液体流动在过滤介质表面产生剪切力,减小了滤饼层或凝胶层的堆积,保证了稳定的过滤速度,可有效提高处理效率。该分离方法基于尺寸、分子量或其他差异使用膜来分离液体溶液或悬浮液中的组分。切向流过滤技术具有使用简单,快速、高效,规模可放大或缩小,同步进行浓缩和洗滤,经济省时等优点。切向流过滤技术可以集合封闭式循环流路,获得高效、无菌和快速的工艺,因此切向流过滤技术常用于生物活性物质的分离,生物制品、血制品及疫苗的生产。Tangential flow filtration (TFF) is a new type of concentrated filtration technology, which refers to a filtration form in which the liquid flow direction is perpendicular to the filtration direction. Compared with the traditional dead end filtration, the liquid flow in the tangential flow filtration system generates shear force on the surface of the filter medium, which reduces the accumulation of the filter cake layer or gel layer and ensures a stable filtration rate. It can effectively improve the processing efficiency. This separation method uses membranes to separate components in a liquid solution or suspension based on size, molecular weight, or other differences. The tangential flow filtration technology has the advantages of simple use, rapidity, high efficiency, scale can be enlarged or reduced, simultaneous concentration and diafiltration, economical and time-saving. Tangential flow filtration technology can integrate a closed circulation flow path to obtain an efficient, sterile and fast process. Therefore, tangential flow filtration technology is often used for the separation of biologically active substances, and the production of biological products, blood products and vaccines.
亲和层析是一种常见的蛋白纯化技术,利用可与生物活性物质(如抗体)特异性结合的介质作为固定相,使液相中相应的生物活性物质选择性结合在固定相上,借以与液相中的其他杂质分开,达到分离提纯的目的。大孔连续色谱(affinity monolithchromatography,简称AMC)是一种新型的亲和层析技术,其固定相由一个单独的连续的多孔材料构成。常见的固定相材料包括琼脂糖(agarose)、二氧化硅(silica)、甲基丙烯酸缩水甘油酯/乙二醇二甲基丙烯酸酯(glycidyl methacrylate/ethylene dimethacrylate)以及Cryogels等。大孔连续色谱具有很多优点,例如可以制作成多种形式填充在柱子、毛细管以及微流体装置中;回压低,液相可以高速流过,达到快速分离和分析的目的;固定相可以根据需要进行修饰改性。Affinity chromatography is a common protein purification technology that uses a medium that can specifically bind to biologically active substances (such as antibodies) as a stationary phase, so that the corresponding biologically active substances in the liquid phase can be selectively bound to the stationary phase, thereby It is separated from other impurities in the liquid phase to achieve the purpose of separation and purification. Macroporous continuous chromatography (affinity monolithchromatography, referred to as AMC) is a new type of affinity chromatography technology, and its stationary phase is composed of a single continuous porous material. Common stationary phase materials include agarose, silica, glycidyl methacrylate/ethylene dimethacrylate (glycidyl methacrylate/ethylene dimethacrylate), and Cryogels. Macroporous continuous chromatography has many advantages, for example, it can be made into various forms to be filled in columns, capillaries and microfluidic devices; the back pressure is low, and the liquid phase can flow at high speed to achieve the purpose of rapid separation and analysis; stationary phase can be carried out according to needs. modification modification.
单克隆抗体是由淋巴细胞杂交瘤产生的、只针对复合抗原分子上某一单个抗原决定簇的特异性抗体。单克隆抗体具有特异性高、均一性高的优点,已迅速应用于诸多领域,包括检验医学诊断试剂、放射免疫显像技术、蛋白质提纯以及肿瘤靶向、自身免疫性疾病、感染性疾病和移植排斥反应等疾病治疗。现在常用的单克隆抗体纯化系统为AKTA蛋白纯化系统,该系统具有自动化程度高的优点,可以实现自动上样、纯化、样品收集、样品分析于一体。但是该系统的弊端是每次纯化时只能连接一种色谱柱,比如Protein A色谱柱、阴/阳离子交换色谱柱、疏水作用色谱柱等。当单克隆抗体细胞发酵液成分复杂时,需要使用3-4种色谱柱进行纯化,利用AKTA蛋白纯化系统纯化单克隆抗体则需要每一种色谱柱使用结束后,重新换上另一种色谱柱,而且每次使用新的色谱柱都需要先调整样品条件,如电导率、pH等。因此,现行的单克隆抗体制备技术复杂,费时费工,导致单克隆抗体的价格也比较高。Monoclonal antibodies are specific antibodies that are produced by lymphocyte hybridomas and are only directed against a single antigenic determinant on the complex antigen molecule. Monoclonal antibodies have the advantages of high specificity and high homogeneity, and have been rapidly used in many fields, including laboratory medicine diagnostic reagents, radioimmunoimaging technology, protein purification and tumor targeting, autoimmune diseases, infectious diseases and transplantation Rejection and other diseases treatment. The commonly used monoclonal antibody purification system is the AKTA protein purification system, which has the advantage of high automation and can realize automatic sample loading, purification, sample collection, and sample analysis. However, the disadvantage of this system is that only one column can be connected for each purification, such as Protein A column, anion/cation exchange column, hydrophobic interaction column, etc. When the composition of the monoclonal antibody cell fermentation broth is complex, 3-4 chromatographic columns need to be used for purification. Using the AKTA protein purification system to purify monoclonal antibodies requires that each chromatographic column should be replaced with another chromatographic column after use. , and every time a new column is used, the sample conditions, such as conductivity, pH, etc., need to be adjusted first. Therefore, the current monoclonal antibody preparation technology is complicated, time-consuming and labor-intensive, resulting in a relatively high price of the monoclonal antibody.
发明内容SUMMARY OF THE INVENTION
为解决AKTA蛋白纯化系统每次纯化时只能连接一种色谱柱,纯化成分复杂的蛋白时需要每一种色谱柱使用结束后,重新换上另一种色谱柱,还要重新调整样品条件导致该方法工序复杂费时费力的问题,本发明提供了一种复用对流色谱系统(multiplexedconvective chromatography,简称MCC)及其用于蛋白纯化的方法,该系统整合了下游的蛋白纯化步骤,实现了由细胞液回收到最后产品纯化的一步操作,可应用于实验室以及中试规模的抗体生产平台。采用的技术方案如下:In order to solve the problem that the AKTA protein purification system can only be connected to one chromatographic column for each purification. When purifying proteins with complex components, each chromatographic column needs to be replaced with another chromatographic column after use, and the sample conditions must be readjusted. The process of this method is complicated, time-consuming and labor-intensive. The present invention provides a multiplexed convective chromatography (MCC for short) and a method for protein purification. It is a one-step operation from liquid recovery to final product purification, which can be applied to laboratory and pilot-scale antibody production platforms. The technical solutions adopted are as follows:
本发明的目的在于提供一种复用对流色谱系统,该复用对流色谱系统包括进料储液罐1,蠕动泵I2,切向流过滤装置3,循环液储液罐4,蠕动泵II5,蠕动泵III6,废弃滤液储液罐7,蠕动泵IV8,大孔连续色谱装置9,蠕动泵V13和中央处理器;其中:所述进料储液罐1通过蠕动泵I2与切向流过滤装置3的进料口相连;所述切向流过滤装置3设有两个出料口,分别为回收滤液出料口和废弃滤液出料口;所述废弃滤液出料口通过蠕动泵III6与废弃滤液储液罐7相连;所述回收滤液出料口分成两个支路,一个支路通过蠕动泵V13与循环液储液罐4的进料口相连,另一个支路通过蠕动泵IV8与大孔连续色谱装置9的总进料口相连;所述循环液储液罐4的出料口通过蠕动泵II5与切向流过滤装置3的进料口相连;所述大孔连续色谱装置9的总出料口与循环液储液罐4的进料口相连;所述中央处理器控制蠕动泵I2、蠕动泵II5、蠕动泵III6、蠕动泵IV8和蠕动泵V13的启动和停止。The object of the present invention is to provide a multiplexing convection chromatography system, the multiplexing convection chromatography system comprises a feed
优选地,所述复用对流色谱系统为单通道复用对流色谱系统,其中大孔连续色谱装置9包括一个大孔连续色谱柱。Preferably, the multiplexed convection chromatography system is a single-channel multiplexed convection chromatography system, wherein the macroporous
更优选地,所述大孔连续色谱柱选自疏水色谱柱,亲和层析柱,分子筛,阴离子交换层析柱,阳离子交换层析柱和复合色谱层析柱中的任意一种。More preferably, the macroporous continuous chromatography column is selected from any one of hydrophobic chromatography column, affinity chromatography column, molecular sieve, anion exchange chromatography column, cation exchange chromatography column and composite chromatography column.
优选地,所述复用对流色谱系统为多通道复用对流色谱系统,其中大孔连续色谱装置9包括多个并联连接的大孔连续色谱柱。Preferably, the multiplexed convection chromatography system is a multi-channel multiplexed convection chromatography system, wherein the macroporous
更优选地,所述多个并联连接的大孔连续色谱柱选自疏水色谱柱,亲和层析柱,分子筛,阴离子交换层析柱,阳离子交换层析柱和复合色谱层析柱中的任意一种并联连接或任意多种并联连接。More preferably, the plurality of macroporous continuous chromatography columns connected in parallel are selected from any of hydrophobic chromatography columns, affinity chromatography columns, molecular sieves, anion exchange chromatography columns, cation exchange chromatography columns and composite chromatography columns. A parallel connection or any number of parallel connections.
优选地,所述进料储液罐1用于储存待纯化处理的粗蛋白溶液、缓冲液和蛋白的存储液。Preferably, the
优选地,在蠕动泵I2与切向流过滤装置3进料口之间的管路上设有压力传感器10,和/或在蠕动泵II5与切向流过滤装置3进料口之间的管路上设有压力传感器10,和/或在蠕动泵IV8与大孔连续色谱装置9的总进料口之间设有压力传感器10,和/或在切向流过滤装置3的废弃滤液出料口和蠕动泵III6之间设有压力传感器10,所有压力传感器10与中央处理器数据相连,将采集的压力信号传送至中央处理器。Preferably, a
优选地,在蠕动泵I2与进料储液罐1之间设有pH和电导率传感器12,和/或在蠕动泵II5与循环液储液罐4的出料口之间设有pH和电导率传感器12;所述pH和电导率传感器12与中央处理器数据连接,pH和电导率传感器12将其所采集的信号传送至中央处理器。Preferably, a pH and
优选地,所述复用对流色谱系统还包括称重装置11,所述称重装置11与循环液储液罐4连接,用于称量循环液储液罐4和/或其所存储的溶液的重量。Preferably, the multiplexed convection chromatography system further includes a
更优选地,所述称重装置11为电子秤。More preferably, the
更优选地,所述称重装置11为重量传感器,所述重量传感器采集循环液储液罐4与其所存储的溶液的重量信息,将其所采集的重量信号传送至中央处理器。More preferably, the
本发明还提供了一种利用上述复用对流色谱系统纯化蛋白的方法,该方法包括如下步骤:The present invention also provides a method for purifying protein by utilizing the above-mentioned multiplexing convection chromatography system, the method comprising the following steps:
1)将待纯化处理的粗蛋白溶液输送至切向流过滤装置3中进行过滤,废弃滤液由蠕动泵III6输送至废弃滤液储液罐7中,回收滤液流动至循环液储液罐4中,循环液储液罐4中回收滤液经称重后由蠕动泵II5输送回切向流过滤装置3中,重复上述过滤过程至达到既定浓缩程度,完成第一阶段的浓缩;1) the crude protein solution to be purified is transported to the tangential
2)将进料储液罐1中的溶液替换为缓冲液,由蠕动泵I2将进料储液罐1中的缓冲液输送至切向流过滤装置3中进行缓冲液置换,在置换过程中将经过置换后的废弃液由蠕动泵III6输送至废弃滤液储液罐7中,置换后的回收液输送至循环液储液罐4中,经称重后由蠕动泵II5输送回切向流过滤装置3中,重复上述置换过程完成缓冲液置换至既定的pH及电导率;2) the solution in the
3)将切向流过滤装置3和循环液储液罐4中的溶液输送至大孔连续色谱装置9进行除杂;3) the solution in the tangential
4)将进料储液罐1中的溶液替换为蛋白的存储液,将经过大孔连续色谱装置9除杂后的溶液重新输送至切向流过滤装置3中进行重复循环以完成二次浓缩和蛋白的存储液的置换;4) The solution in the feeding
5)完成二次浓缩后,收集溶液即得纯化后的蛋白溶液。5) After the secondary concentration is completed, the solution is collected to obtain the purified protein solution.
更优选地,所述方法包括如下步骤:More preferably, the method includes the steps of:
1)将待纯化处理的粗蛋白溶液储存于进料储液罐1中,通过中央处理器启动蠕动泵I2、蠕动泵II5、蠕动泵III6和蠕动泵V13,关闭蠕动泵IV8,将进料储液罐1中的待纯化处理的粗蛋白溶液输送至切向流过滤装置3中进行过滤,在过滤过程中将废弃滤液由蠕动泵III6输送至废弃滤液储液罐7中,回收滤液输送至循环液储液罐4中,经称重后由蠕动泵II5输送回切向流过滤装置3中,重复上述过滤过程至达到既定浓缩程度,完成第一阶段的浓缩;1) the crude protein solution to be purified is stored in the
2)将进料储液罐1中的溶液替换为缓冲液,由蠕动泵I2将进料储液罐1中的缓冲液输送至切向流过滤装置3中进行缓冲液置换,在置换过程中将经过置换后的废弃液由蠕动泵III6输送至废弃滤液储液罐7中,置换后的回收液输送至循环液储液罐4中,经称重后由蠕动泵II5输送回切向流过滤装置3中,重复上述置换过程完成缓冲液置换至既定的pH及电导率;2) the solution in the
3)通过中央处理器启动蠕动泵II5和蠕动泵IV8,关闭蠕动泵V13,使得切向流过滤装置3和循环液储液罐4中的溶液进入大孔连续色谱装置9进行除杂,经过大孔连续色谱装置9除杂后的溶液进入循环液储液罐4中存储;3) start peristaltic pump II5 and peristaltic pump IV8 by central processing unit, close peristaltic pump V13, make the solution in tangential
4)通过中央处理器启动蠕动泵I2、蠕动泵II5、蠕动泵III6和蠕动泵V13,关闭蠕动泵IV8,将进料储液罐1中的溶液替换为蛋白的存储液,将循环液储液罐4中存储的经过大孔连续色谱装置9除杂后的溶液输送至切向流过滤装置3中进行重复循环处理以完成二次浓缩和蛋白的存储液的置换,最终处理的液体由循环液储液罐4储存;4) start peristaltic pump I2, peristaltic pump II5, peristaltic pump III6 and peristaltic pump V13 by central processing unit, close peristaltic pump IV8, the solution in the
5)通过中央处理器关闭蠕动泵I2、蠕动泵II5、蠕动泵III6、蠕动泵V13和蠕动泵IV8,收集循环液储液罐4中的溶液,即得纯化后的蛋白溶液。5) close peristaltic pump I2, peristaltic pump II5, peristaltic pump III6, peristaltic pump V13 and peristaltic pump IV8 by central processing unit, collect the solution in the circulating
优选地,所述待纯化处理的粗蛋白溶液为单克隆抗体细胞发酵液。更优选地,步骤5)所述二次浓缩至浓缩液的浓度为1~5mg/mL。Preferably, the crude protein solution to be purified is a monoclonal antibody cell fermentation broth. More preferably, the concentration of the concentrated solution in step 5) is 1-5 mg/mL by the secondary concentration.
本发明复用对流色谱系统包括切向流过滤系统(TFF)和大孔连续色谱(AMC),根据单克隆抗体细胞发酵液成分的复杂程度,可以开发单通道复用对流色谱系统和多通道复用对流色谱系统,单克隆抗体细胞发酵液成分简单的情况,使用单通道复用对流色谱系统可实现由细胞液回收到最后产品纯化的一步操作;单克隆抗体细胞发酵液成分复杂的情况,使用多通道复用对流色谱系统可实现由细胞液回收到最后产品纯化的一步操作。The multiplexed convection chromatography system of the invention includes a tangential flow filtration system (TFF) and a macroporous continuous chromatography (AMC). According to the complexity of the components of the monoclonal antibody cell fermentation broth, a single-channel multiplexed convection chromatography system and a multi-channel complex With the convection chromatography system, when the composition of the monoclonal antibody cell fermentation broth is simple, the single-channel multiplexing convection chromatography system can realize one-step operation from the recovery of the cell liquid to the final product purification; when the composition of the monoclonal antibody cell fermentation broth is complex, use The multi-channel multiplexed convection chromatography system can realize one-step operation from cell fluid recovery to final product purification.
单通道复用对流色谱系统可以由一个切向流过滤装置、一个大孔连续色谱柱、五个蠕动泵、三个压力传感器、两个pH/电导率传感器、一个循环液储液罐器、一个进料储液罐、一个废弃滤液储液罐组成形成循环流路。外连一台称重装置和一台中央处理器控制循环液流动及蠕动泵开和关。The single-channel multiplexed convection chromatography system can consist of a tangential flow filtration device, a macroporous continuous chromatography column, five peristaltic pumps, three pressure sensors, two pH/conductivity sensors, a circulating fluid reservoir, a A feed liquid storage tank and a waste filtrate liquid storage tank form a circulating flow path. An external weighing device and a central processing unit are connected to control the flow of circulating fluid and the opening and closing of the peristaltic pump.
多通道复用对流色谱系统可以由一个切向流过滤装置、多个大孔连续色谱柱、五个蠕动泵、三个压力传感器、两个pH/电导率传感器、一个循环液储液罐、一个进料储液罐、一个废弃滤液储液罐出口组成形成循环流路。外连一台称重装置和一台中央处理器控制循环液流动及蠕动泵开和关。The multi-channel multiplexed convection chromatography system can consist of a tangential flow filter device, multiple macroporous continuous chromatography columns, five peristaltic pumps, three pressure sensors, two pH/conductivity sensors, a circulating fluid reservoir, a The feed liquid storage tank and the outlet of a waste filtrate liquid storage tank form a circulating flow path. An external weighing device and a central processing unit are connected to control the flow of circulating fluid and the opening and closing of the peristaltic pump.
本发明复用对流色谱系统可以用于纯化蛋白,尤其是适用于单克隆抗体,利用本发明复用对流色谱系统处理单克隆抗体的方法为:将单克隆抗体细胞发酵液通过进料口进入复用对流色谱系统,首先进入切向流过滤系统进行样品浓缩;在样品浓缩至一定程度时,从进料口添加缓冲液进行缓冲液置换;经过切向流过滤系统浓缩和缓冲液置换后的样品进入大孔连续色谱进行一步或多步除杂;经过大孔连续色谱处理后,样品重新进入切向流过滤系统进行浓缩。二次浓缩过程中,从进料口添加单克隆抗体存储液,对样品进行存储液置换;样品经过存储液置换并浓缩到特定的浓度范围后,切向流过滤系统和大孔连续色谱系统下线,样品由收集管收集、存储。The multiplexed convection chromatography system of the present invention can be used for purifying proteins, and is especially suitable for monoclonal antibodies. The method for using the multiplexed convection chromatography system of the present invention to process the monoclonal antibodies is as follows: the monoclonal antibody cell fermentation broth is introduced into the complex through the feed port. With the convection chromatography system, first enter the tangential flow filtration system for sample concentration; when the sample is concentrated to a certain extent, add buffer from the feed port for buffer exchange; the sample after concentration and buffer exchange through the tangential flow filtration system Enter the macroporous continuous chromatography for one or more steps of impurity removal; after the macroporous continuous chromatography treatment, the sample re-enters the tangential flow filtration system for concentration. During the secondary concentration process, the monoclonal antibody storage solution was added from the feed port, and the sample was replaced by the storage solution; after the sample was replaced by the storage solution and concentrated to a specific concentration range, the tangential flow filtration system and the macroporous continuous chromatography system were used. The sample is collected and stored in the collection tube.
本发明中缓冲液成分根据大孔连续色谱的吸附介质确定。In the present invention, the buffer composition is determined according to the adsorption medium of macroporous continuous chromatography.
本发明中的待纯化处理的粗蛋白溶液是指获得的发酵细胞经离心、细胞破碎、离心、过滤后初步纯化后得到的粗蛋白溶液。The crude protein solution to be purified in the present invention refers to the crude protein solution obtained after preliminary purification of the obtained fermented cells through centrifugation, cell disruption, centrifugation and filtration.
本发明中蛋白的存储液是指用于存储纯化后蛋白的溶液。The storage solution of protein in the present invention refers to a solution for storing purified protein.
本发明中大孔连续色谱柱是指基于大孔连续色谱技术的蛋白层析柱,即该色谱柱是将大孔连续色谱技术与蛋白层析相结合的纯化柱,如疏水色谱柱,亲和层析柱,分子筛,阴离子交换层析柱,阳离子交换层析柱,复合色谱层析柱,或其他基于大孔连续色谱技术的蛋白层析柱。本发明有益效果:The macroporous continuous chromatography column in the present invention refers to a protein chromatography column based on macroporous continuous chromatography technology, that is, the chromatography column is a purification column that combines macroporous continuous chromatography technology with protein chromatography, such as a hydrophobic chromatography column, an affinity Chromatography column, molecular sieve, anion exchange chromatography column, cation exchange chromatography column, composite chromatography column, or other protein chromatography column based on macropore continuous chromatography technology. Beneficial effects of the present invention:
本发明中切向流过滤装置起浓缩作用、缓冲溶液置换以及蛋白存储液置换的作用,大孔连续色谱装置起纯化作用,本发明系统充分利用了色谱柱高通量、耐压性强,结合切向流过滤系统,集细胞上清液的浓缩、缓冲液置换、纯化以及最后产品的配方于一体;同时,该系统整合了下游的纯化步骤,无需更换色谱柱,重新调整条件,实现了由细胞液回收到最后产品纯化的一步操作,可以达到省时省力、经济高效的纯化目的。此外,该系统可以进一步集成紫外光探测、pH、电导仪等实现对整个纯化过程的实时监测,最终建立高效、简便、经济的实验室、中试规模抗体生产平台,在各种蛋白纯化中试平台具有很大的应用前景。In the present invention, the tangential flow filtration device plays the role of concentration, buffer solution replacement and protein storage solution replacement, and the macroporous continuous chromatography device plays the role of purification. The tangential flow filtration system integrates the concentration of cell supernatant, buffer exchange, purification and formulation of the final product; at the same time, the system integrates the downstream purification steps, eliminating the need to replace the chromatographic column and readjust the conditions. The one-step operation from cell liquid recovery to final product purification can achieve the purpose of time-saving, labor-saving, economical and efficient purification. In addition, the system can further integrate ultraviolet light detection, pH, conductivity meter, etc. to realize real-time monitoring of the entire purification process, and finally establish an efficient, simple and economical laboratory and pilot-scale antibody production platform, which can be used in various protein purification pilot scales. The platform has great application prospects.
本发明系统具有较好的纯化效果,如处理单克隆抗体蛋白,纯化前细胞发酵液中,宿主蛋白(Host cell protein,HCP)含量为300,000ppm,DNA含量为30,000ppm。经过辛酸-尿囊素-离心-过滤预处理后,HCP含量降低至500ppm以下,经过单通道复用对流色谱系统纯化后,HCP含量小于100ppm,DNA含量小于10ppm;IgG1纯度为95%以上,回收率高于85%。The system of the invention has better purification effect, such as processing monoclonal antibody protein, the content of host cell protein (HCP) in the cell fermentation broth before purification is 300,000 ppm, and the content of DNA is 30,000 ppm. After octanoic acid-allantoin-centrifugation-filtration pretreatment, the HCP content was reduced to less than 500ppm. After purification by a single-channel multiplexed convection chromatography system, the HCP content was less than 100ppm and the DNA content was less than 10ppm; the purity of IgG1 was over 95%, and the recovered rate is higher than 85%.
附图说明Description of drawings
图1为单通道复用对流色谱的结构示意图;Fig. 1 is the structural representation of single-channel multiplexed convection chromatography;
图2为单通道复用对流色谱的纯化原理图;Fig. 2 is the purification principle diagram of single-channel multiplexed convection chromatography;
图3为多通道复用对流色谱的结构示意图;Fig. 3 is the structural representation of multi-channel multiplexing convection chromatography;
图4为多通道复用对流色谱的纯化原理图;Fig. 4 is the purification principle diagram of multi-channel multiplexing convection chromatography;
图中:1,进料储液罐;2,蠕动泵I;3,切向流过滤装置;4,循环液储液罐;5,蠕动泵II;6,蠕动泵III;7,废弃滤液储液罐;8,蠕动泵IV;9,大孔连续色谱装置;10,压力传感器;11,称重装置;12,pH和电导率传感器;13,蠕动泵V。In the figure: 1, feed storage tank; 2, peristaltic pump I; 3, tangential flow filter device; 4, circulating fluid storage tank; 5, peristaltic pump II; 6, peristaltic pump III; 7, waste filtrate storage liquid tank; 8, peristaltic pump IV; 9, macroporous continuous chromatography device; 10, pressure sensor; 11, weighing device; 12, pH and conductivity sensor; 13, peristaltic pump V.
具体实施方式Detailed ways
下面结合具体实施例对本发明做进一步说明,但本发明不受实施例的限制。The present invention will be further described below in conjunction with specific embodiments, but the present invention is not limited by the embodiments.
实施例1Example 1
如图1所示,本实施例提供了一种单通道复用对流色谱系统包括进料储液罐1,蠕动泵I2,切向流过滤装置3,循环液储液罐4,蠕动泵II5,蠕动泵III6,废弃滤液储液罐7,蠕动泵IV8,大孔连续色谱装置9,蠕动泵V13和中央处理器;其中:所述进料储液罐1通过蠕动泵I2与切向流过滤装置3的进料口相连;所述切向流过滤装置3设有两个出料口,分别为回收滤液出料口和废弃滤液出料口;所述废弃滤液出料口通过蠕动泵III6与废弃滤液储液罐7相连;所述回收滤液出料口分成两个支路,一个支路通过蠕动泵V13与循环液储液罐4的进料口相连,另一个支路通过蠕动泵IV8与大孔连续色谱装置9的总进料口相连;所述循环液储液罐4的出料口通过蠕动泵II5与切向流过滤装置3的进料口相连;所述大孔连续色谱装置9的总出料口与循环液储液罐4的进料口相连;所述中央处理器控制蠕动泵I2、蠕动泵II5、蠕动泵III6、蠕动泵IV8和蠕动泵V13的启动和停止。As shown in FIG. 1, the present embodiment provides a single-channel multiplexing convection chromatography system including a feed
本实施例复用对流色谱系统为单通道复用对流色谱系统,其中大孔连续色谱装置9包括一个大孔连续色谱柱。大孔连续色谱柱选自疏水色谱柱,亲和层析柱,分子筛,阴离子交换层析柱,阳离子交换层析柱和复合色谱层析柱中的任意一种。切向流过滤装置3包括切向流过滤柱。The multiplexed convection chromatography system in this embodiment is a single-channel multiplexed convection chromatography system, wherein the macroporous
本实施例的进料储液罐1用于分别储存待纯化处理的粗蛋白溶液、缓冲液和蛋白存储液。The
作为本实施例的一种优选方式,在蠕动泵I2与切向流过滤装置3进料口之间的管路上、在蠕动泵II5与切向流过滤装置3进料口之间的管路上、在蠕动泵IV8与大孔连续色谱装置9的总进料口之间以及在废弃滤液出料口和蠕动泵III6之间均设有压力传感器10;所有压力传感器10与中央处理器数据相连,将采集到的压力信号输送至中央处理器。As a preferred way of this embodiment, on the pipeline between the peristaltic pump I2 and the feed port of the tangential
作为本实施例的一种优选方式,在蠕动泵I2与进料储液罐1之间、以及在蠕动泵II5与循环液储液罐4的出料口之间均设有pH和电导率传感器12;pH和电导率传感器12与中央处理器数据连接,pH/电导率传感器将其所采集的信号传送至中央处理器。As a preferred mode of this embodiment, pH and conductivity sensors are provided between the peristaltic pump I2 and the
作为本实施例的一种优选方式,所述复用对流色谱系统还包括称重装置11,所述称重装置11与循环液储液罐4连接,用于称量循环液储液罐4内溶液的重量。称重装置11可以为电子秤,直接称量循环液储液罐4与其所存储的溶液的的重量;称重装置11还可以是重量传感器,重量传感器采集循环液储液罐4与其所存储的溶液的重量信息,将其所采集的重量信号传送至中央处理器。As a preferred mode of this embodiment, the multiplexed convection chromatography system further includes a weighing
本实施例的单通道复用对流色谱系统技术原理图如图2所示。The technical schematic diagram of the single-channel multiplexing convection chromatography system of this embodiment is shown in FIG. 2 .
本实施例还提供了一种利用上述复用对流色谱系统纯化蛋白的方法,该方法包括如下步骤:This embodiment also provides a method for purifying protein by utilizing the above-mentioned multiplexed convection chromatography system, the method comprising the following steps:
1)将待纯化处理的粗蛋白溶液,如单克隆抗体细胞发酵液,储存于进料储液罐1中,通过中央处理器启动蠕动泵I2、蠕动泵II5、蠕动泵III6和蠕动泵V13,关闭蠕动泵IV8,将进料储液罐1中的待纯化处理的粗蛋白溶液输送至切向流过滤装置3中进行过滤,在过滤过程中将废弃滤液由蠕动泵III6输送至废弃滤液储液罐7中,回收滤液输送至循环液储液罐4中,经称重装置11称重后由蠕动泵II5输送回切向流过滤装置3中,重复上述过滤过程至达到既定浓缩程度,完成第一阶段的浓缩;1) crude protein solution to be purified, such as monoclonal antibody cell fermentation broth, is stored in
2)将进料储液罐1中的溶液替换为缓冲液,由蠕动泵I2将进料储液罐1中的缓冲液输送至切向流过滤装置3中进行缓冲液置换,在置换过程中将经过置换后的废弃液由蠕动泵III6输送至废弃滤液储液罐7中,置换后的回收液输送至循环液储液罐4中,经称重装置11称重后由蠕动泵II5输送回切向流过滤装置3中,重复上述置换过程完成缓冲液置换至既定的pH及电导率;2) the solution in the
3)通过中央处理器启动蠕动泵II5和蠕动泵IV8,关闭蠕动泵V13,使得切向流过滤装置3和循环液储液罐4中的溶液进入大孔连续色谱装置9进行除杂纯化,当污染物吸附趋近平衡,大孔连续色谱下线,经过大孔连续色谱装置9除杂后的溶液进入循环液储液罐4中存储;3) start peristaltic pump II5 and peristaltic pump IV8 by central processing unit, close peristaltic pump V13, make the solution in tangential
4)通过中央处理器启动蠕动泵I2、蠕动泵II5、蠕动泵III6和蠕动泵V13,关闭蠕动泵IV8,将进料储液罐1中的溶液替换为蛋白的存储液,将循环液储液罐4中存储的经过大孔连续色谱装置9除杂后的溶液输送至切向流过滤装置3中进行重复循环处理以完成二次浓缩和蛋白的存储液的置换,最终处理的液体由循环液储液罐4储存;4) start peristaltic pump I2, peristaltic pump II5, peristaltic pump III6 and peristaltic pump V13 by central processing unit, close peristaltic pump IV8, the solution in the
5)当单克隆抗体浓度达到1mg/mL时,通过中央处理器关闭蠕动泵I2、蠕动泵II5、蠕动泵III6、蠕动泵V13和蠕动泵IV8,收集循环液储液罐4中的溶液,即得纯化后的蛋白溶液。5) when monoclonal antibody concentration reaches 1mg/mL, close peristaltic pump I2, peristaltic pump II5, peristaltic pump III6, peristaltic pump V13 and peristaltic pump IV8 by central processing unit, collect the solution in circulating
实施例2Example 2
如图3所示,本实施例与实施例1的区别在于:复用对流色谱系统为多通道复用对流色谱系统,其中大孔连续色谱装置9包括2个并联连接的大孔连续色谱柱。其中2个并联连接的大孔连续色谱柱分别为阴离子交换层析柱和疏水色谱柱。也可以是选自疏水色谱柱,亲和层析柱,分子筛,阴离子交换层析柱,阳离子交换层析柱和复合色谱层析柱中的任意组合。As shown in FIG. 3 , the difference between this embodiment and
本实施例的多通道复用对流色谱系统技术原理图如图4所示。The technical schematic diagram of the multi-channel multiplexing convection chromatography system of this embodiment is shown in FIG. 4 .
本实施例的纯化方法与实施例1的区别在于:当单克隆抗体浓度达到5mg/mL时,TFF系统下线,样品处理结束,最终纯化样品由收集管收集、存储。The difference between the purification method in this example and Example 1 is that when the monoclonal antibody concentration reaches 5 mg/mL, the TFF system goes offline, the sample processing ends, and the final purified sample is collected and stored in a collection tube.
实施例3Example 3
以单克隆抗体IgG1为例,说明单通道复用对流色谱系统可完成从细胞发酵液浓缩、回收到纯化的一步操作。Taking the monoclonal antibody IgG1 as an example, it shows that the single-channel multiplexed convection chromatography system can complete the one-step operation from concentration, recovery to purification of cell fermentation broth.
细胞培养:单克隆抗体IgG1由中国仓鼠卵巢细胞(Chinese Hamster Ovary,CHO)表达产生,抗体在5升B搅拌式玻璃生物反应器中生产,采用分批补料的培养方式,培养15~30天后收集细胞发酵液。细胞培养基为无蛋白培养基CD CHO(LifeTechnologies)和无蛋白培养基PF-CHO(GE Healthcare)的混合物,两者体积比为1:1。Cell culture: Monoclonal antibody IgG1 was expressed by Chinese Hamster Ovary cells (Chinese Hamster Ovary, CHO). B is produced in a stirred glass bioreactor, and the culture method of fed-batch is adopted, and the cell fermentation broth is collected after culturing for 15 to 30 days. Cell culture medium is protein-free medium CD CHO (LifeTechnologies) and protein-free medium A mixture of PF-CHO (GE Healthcare) in a volume ratio of 1:1.
细胞发酵液预处理:将细胞发酵液pH调至5.3,加入辛酸和尿囊素,使辛酸和尿囊素在上述混合物中的最终质量浓度分别为0.4%和1%。混合物室温搅拌2小时,然后4000×g、室温条件下离心20min,收集上清液经由0.22μm滤膜(Rapid-Flow Filters,Thermo Scientific)过滤,收集过滤液。Cell fermentation broth pretreatment: the pH of the cell fermentation broth was adjusted to 5.3, and caprylic acid and allantoin were added to make the final mass concentrations of caprylic acid and allantoin in the above mixture 0.4% and 1%, respectively. The mixture was stirred at room temperature for 2 hours, then centrifuged at 4000 × g for 20 min at room temperature, and the supernatant was collected through a 0.22 μm filter ( Rapid-Flow Filters, Thermo Scientific) to collect the filtrate.
过滤液(约5升)置于进料储液罐1中,经由蠕动泵I进入切向流过滤装置3(切向流过滤柱,TFF),废弃滤液经蠕动泵III6废弃滤液储液罐7排出系统,经过切向流过滤装置3浓缩的样品进入循环液储液罐4中称重后再次进入TFF柱进行浓缩。当循环液体积浓缩至约3升时,在进料储液罐1中添加Tris-HCl缓冲液(pH 7.5),Tris-HCl缓冲液进入TFF柱对浓缩的样品进行缓冲液置换。循环液经缓冲液置换后,由中央处理器控制大孔连续色谱装置9(单通道复用对流色谱系统,大孔连续色谱柱采用阴离子交换层析柱)前端蠕动泵IV8开启,循环液进入大孔连续色谱装置9(阴离子交换柱)开始IgG1纯化,循环液全部从大孔连续色谱装置9(阴离子交换柱)流出后,纯化结束AMC系统下线。纯化后IgG1进入TFF系统进一步浓缩,同时在进料储液罐1中添加PBS缓冲液(pH 7.2-7.4,10mM)作为单克隆抗体存储液,对IgG1进行存储液置换。当IgG1浓度达到3mg/mL时,TFF系统下线,样品处理结束,最终纯化样品由收集管收集、存储。宿主蛋白含量通过Generation III CHO HCP试剂盒检测,DNA含量通过数字型PCR仪QX100TMDroplet DigitalTMPCR System(Bio-Rad)检测。Filtrate (about 5 liters) is placed in
实验结果:纯化前细胞发酵液中,宿主蛋白(Host cell protein,HCP)含量为300,000ppm,DNA含量为30,000ppm。经过辛酸-尿囊素-离心-过滤预处理后,HCP含量降低至500ppm以下。经过单通道复用对流色谱系统纯化后,HCP含量小于100ppm,DNA含量小于10ppm;IgG1纯度为95%以上,回收率高于85%。符合现有美国食品和药物管理局(Food anddrug administration,FDA)对单克隆抗体蛋白产品的要求。Experimental results: In the cell fermentation broth before purification, the content of host cell protein (HCP) was 300,000 ppm, and the content of DNA was 30,000 ppm. After octanoic acid-allantoin-centrifugation-filtration pretreatment, the HCP content was reduced to below 500ppm. After being purified by a single-channel multiplexed convection chromatography system, the content of HCP is less than 100 ppm, and the content of DNA is less than 10 ppm; the purity of IgG1 is over 95%, and the recovery rate is higher than 85%. Comply with the existing U.S. Food and Drug Administration (FDA) requirements for monoclonal antibody protein products.
虽然本发明已以较佳的实施例公开如上,但其并非用以限定本发明,任何熟悉此技术的人,在不脱离本发明的精神和范围内,都可以做各种改动和修饰,因此本发明的保护范围应该以权利要求书所界定的为准。Although the present invention has been disclosed above with preferred embodiments, it is not intended to limit the present invention. Anyone who is familiar with this technology can make various changes and modifications without departing from the spirit and scope of the present invention. Therefore, The protection scope of the present invention should be defined by the claims.
Claims (10)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201811529395.9A CN111318077A (en) | 2018-12-13 | 2018-12-13 | A multiplexed convection chromatography system and method for purifying protein |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201811529395.9A CN111318077A (en) | 2018-12-13 | 2018-12-13 | A multiplexed convection chromatography system and method for purifying protein |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN111318077A true CN111318077A (en) | 2020-06-23 |
Family
ID=71163072
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201811529395.9A Pending CN111318077A (en) | 2018-12-13 | 2018-12-13 | A multiplexed convection chromatography system and method for purifying protein |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN111318077A (en) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2022076318A1 (en) * | 2020-10-05 | 2022-04-14 | Bristol-Myers Squibb Company | Methods for concentrating proteins |
| CN114957377A (en) * | 2021-02-26 | 2022-08-30 | 重庆誉颜制药有限公司 | System for preparing polypeptide and application thereof |
| CN115282779A (en) * | 2022-07-27 | 2022-11-04 | 山东泰邦生物制品有限公司 | Unidirectional flow ultrafiltration system for realizing dialysis function and operation method thereof |
| CN116899272A (en) * | 2022-04-15 | 2023-10-20 | 思拓凡美国有限公司 | Chromatography equipment and methods of use |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2014001979A (en) * | 2012-06-15 | 2014-01-09 | National Institute Of Advanced Industrial & Technology | Protein separation purification device and separation purification method |
| CN106457153A (en) * | 2014-03-07 | 2017-02-22 | 新加坡科技研究局 | Apparatus and methods for fractionation of biological products |
| CN207385203U (en) * | 2017-10-23 | 2018-05-22 | 郑州伊美诺生物技术有限公司 | Albumen automatic ration enrichment facility |
| CN209362021U (en) * | 2018-12-13 | 2019-09-10 | 中国科学院青岛生物能源与过程研究所 | A multiplexed convection chromatography system |
-
2018
- 2018-12-13 CN CN201811529395.9A patent/CN111318077A/en active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2014001979A (en) * | 2012-06-15 | 2014-01-09 | National Institute Of Advanced Industrial & Technology | Protein separation purification device and separation purification method |
| CN106457153A (en) * | 2014-03-07 | 2017-02-22 | 新加坡科技研究局 | Apparatus and methods for fractionation of biological products |
| CN207385203U (en) * | 2017-10-23 | 2018-05-22 | 郑州伊美诺生物技术有限公司 | Albumen automatic ration enrichment facility |
| CN209362021U (en) * | 2018-12-13 | 2019-09-10 | 中国科学院青岛生物能源与过程研究所 | A multiplexed convection chromatography system |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2022076318A1 (en) * | 2020-10-05 | 2022-04-14 | Bristol-Myers Squibb Company | Methods for concentrating proteins |
| JP2023544410A (en) * | 2020-10-05 | 2023-10-23 | ブリストル-マイヤーズ スクイブ カンパニー | Methods for concentrating proteins |
| CN114957377A (en) * | 2021-02-26 | 2022-08-30 | 重庆誉颜制药有限公司 | System for preparing polypeptide and application thereof |
| CN116899272A (en) * | 2022-04-15 | 2023-10-20 | 思拓凡美国有限公司 | Chromatography equipment and methods of use |
| CN115282779A (en) * | 2022-07-27 | 2022-11-04 | 山东泰邦生物制品有限公司 | Unidirectional flow ultrafiltration system for realizing dialysis function and operation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP3828143B2 (en) | Improved tangential flow filtration method and apparatus | |
| KR102027596B1 (en) | Continuous processing methods for biological products | |
| RU2610667C2 (en) | Method of purification of proteins | |
| KR102386215B1 (en) | Continuous diafiltration by tank cycling | |
| JP7568638B2 (en) | Continuous production of recombinant proteins | |
| CN111318077A (en) | A multiplexed convection chromatography system and method for purifying protein | |
| US20130115588A1 (en) | Integrated bioreactor and separation system and methods of use therof | |
| RU2015142657A (en) | INTEGRATED CONTINUOUS PRODUCTION OF THERAPEUTIC PROTEIN MEDICINES | |
| JP2017502666A (en) | Equipment for cell culture | |
| KR20160138949A (en) | Ultrafiltration unit for continuous buffer or media exchange from a protein solution | |
| CN114317227A (en) | Exosome purification method and all-in-one machine device thereof | |
| CN115094030B (en) | Purification method of clinical-grade high-purity exosome | |
| US20210107938A1 (en) | Polypeptide separation method, polypeptide production method, and polypeptide purification device | |
| CN209362021U (en) | A multiplexed convection chromatography system | |
| JP2023145471A (en) | In-line product concentration to reduce volumetric load flow rate and increase productivity of bind and elute chromatography purification | |
| CN114829371A (en) | Enhanced virus filtration using diafiltration buffer | |
| CN115747049B (en) | A separation and purification device for stem cell exosomes and paracrine active macromolecules and a method for using the same | |
| RU2842054C2 (en) | Continuous production of recombinant proteins | |
| CN214345637U (en) | A hierarchical extraction element that is arranged in external cell culture liquid skin cell growth factor | |
| CN109320603A (en) | A kind of system and method for serialization purification antibody | |
| CN106317166A (en) | Device for separating proteins by using high-rate filtration and chromatography mixed mechanism | |
| CN116236820A (en) | Continuous production system of single plasma IgG (immunoglobulin G) product | |
| CN118344486A (en) | A purification method for producing a recombinant anti-CD19-CD3 bispecific antibody Fab fragment | |
| HK1227350A1 (en) | Ultrafiltration unit for continuous buffer or media exchange from a protein solution | |
| JP2001149472A (en) | Purification method of bioactive substance |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20200623 |